Aktie 6472 BORA PHARMACEUTICALS CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Bora Pharmaceuticals Co., LTD.

Aktien

6472

TW0006472004

6472

Schlusskurs Taiwan S.E.
Andere Börsenplätze
 00:00:00 26.04.2024 		% 5 Tage % 1. Jan.
752 TWD -0.53% Intraday Chart für Bora Pharmaceuticals Co., LTD. +6.52% +17.68%
01.04. Bora Pharmaceuticals Co., LTD. (TWSE:6472) hat die Übernahme von Sawai America Holdings Inc. von Sawai Group Holdings Co., Ltd. (TSE:4887) ABGESCHLOSSEN. CI
07.03. Bora Pharmaceuticals Co., LTD. (TWSE:6472) kündigt einen Aktienrückkauf für 1.000.000 Aktien an, was 0,99% für TWD 6.832,17 Millionen entspricht. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Bora Pharmaceuticals Co., LTD. agreed to acquire remaining 34.3% stake in Bora Biologics Co., Ltd.
Bora Pharmaceuticals Co., LTD. completed the acquisition of Sawai America Holdings Inc. from Sawai Group Holdings Co., Ltd..
Bora Pharmaceuticals USA Inc. announced that it expects to receive $1 billion in funding from Bora Pharmaceuticals Co., LTD.
Bora Pharmaceuticals Co., LTD. announces an Equity Buyback for 1,000,000 shares, representing 0.99% for TWD 6,832.17 million.
Bora Pharmaceuticals Co., LTD. Announces Cash Dividend for Second Half of 2023
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the Full Year Ended December 31, 2023
Bora Pharmaceuticals Co., LTD. authorizes a Buyback Plan.
Bora Pharmaceuticals USA Inc. announced that it expects to receive $100 million in funding from Bora Pharmaceuticals Co., LTD.
Bora Pharmaceuticals Co., LTD.(TWSE:6472) added to Taiwan TAIEX Index
Bora Pharmaceuticals Co., LTD. agreed to acquire Sawai America Holdings Inc. from Sawai Group Holdings Co., Ltd. for approximately $210 million.
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
SunWay Biotech Co., LTD. agreed to acquire Bora Health Inc from Bora Pharmaceuticals Co., LTD..
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Bora Pharmaceuticals Co., Ltd. Elects Lin Hsin-I as Independent Director
Bora Pharmaceuticals Co., Ltd. Announces Cash Dividend, Payable on July 28, 2023
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the Full Year Ended December 31, 2022
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Bora Pharmaceuticals Co., LTD. Announces Contract Signing of the Syndicated Loan with Syndicate Bank
Bora Pharmaceuticals Co., LTD. completed the acquisition of TWi Pharmaceuticals, Inc.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 6472 Aktie
  4. Nachrichten Bora Pharmaceuticals Co., LTD.
  5. Andere Sprachen